Skip to main content
Equibles
RLAY logo

RLAY · Relay Therapeutics, Inc. · Held by Funds

Track RLAY — free

Use RLAY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RLAY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.33 -0.01 (-0.05%)
Russell 2000 member Rebalance outlook locked
Market Cap
$4.02B
Shares
219.14M
Volume · Oct 23 1.9M Avg daily vol (3M) 2.75M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of RLAY by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 14.42% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.41% 5,285,487
Index ETFs 12.01% 26,325,313
Active ETFs 0.96% 2,097,804
Active funds 11.84% 25,936,047
Unclassified 0.21% 468,097
All registered funds 27.43% 60,112,748
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding RLAY

293 fund positions
Fund Balance Value % of Fund Open
VANGUARD TOTAL STOCK MARKET INDEX FUND 6,800,083 $127,229,553 0.01%
State Street(R) SPDR(R) S&P(R) Biotech ETF 6,304,701 $117,960,956 1.10%
iShares Russell 2000 ETF 4,163,646 $77,901,817 0.09%
VANGUARD EXTENDED MARKET INDEX FUND 1,943,788 $36,368,273 0.04%
Fidelity Small Cap Growth Fund 1,917,750 $36,111,233 0.41%
Fidelity Advisor Biotechnology Fund 1,850,700 $34,848,681 1.58%
T. Rowe Price Health Sciences Fund, Inc. 1,840,896 $34,443,164 0.29%
Fidelity Small Cap Index Fund 1,767,834 $33,288,314 0.10%
Harbor Small Cap Growth Fund 1,681,000 $31,653,230 1.19%
Fidelity Stock Selector Small Cap Fund 1,680,415 $31,642,214 0.43%
T. Rowe Price New Horizons Fund, Inc. 1,574,152 $29,452,384 0.20%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 1,366,611 $25,569,292 0.26%
Select Health Care Portfolio 1,680,000 $23,604,000 0.41%
iShares Russell 2000 Growth ETF 1,128,810 $21,120,035 0.14%
Fidelity Advisor Health Care Fund 1,040,000 $19,583,200 0.63%
iShares Biotechnology ETF 1,015,921 $19,007,882 0.21%
Fidelity Small Cap Growth K6 Fund 994,880 $18,733,590 0.41%
AB Small Cap Growth Portfolio 997,328 $18,660,007 0.60%
Fidelity Series Small Cap Opportunities Fund 964,800 $18,167,184 0.38%
Strategic Advisers Fidelity U.S. Total Stock Fund 1,285,400 $18,059,870 0.01%
AB DISCOVERY GROWTH FUND, INC. 877,350 $16,415,219 0.57%
VANGUARD EXPLORER FUND 864,945 $16,286,914 0.07%
Select Biotechnology Portfolio 1,010,467 $14,197,061 0.27%
T. Rowe Price Small-Cap Stock Fund, Inc. 693,879 $12,982,476 0.14%
Fidelity U.S. Equity Central Fund 690,000 $12,909,900 0.05%
U.S. SMALL CAP PORTFOLIO 667,465 $12,568,366 0.06%
Fidelity Extended Market Index Fund 800,737 $11,250,355 0.03%
Dimensional U.S. Small Cap ETF 592,247 $11,152,011 0.07%
VANGUARD RUSSELL 2000 INDEX FUND 767,024 $10,776,687 0.06%
Franklin Small Cap Growth Fund 567,916 $10,693,858 0.43%
Schwab U.S. Small-Cap ETF 744,250 $10,456,713 0.05%
U.S. MICRO CAP PORTFOLIO 507,597 $9,558,052 0.12%
Fidelity Small Cap Discovery Fund 485,900 $9,149,497 0.40%
First Trust Small Cap Growth AlphaDEX Fund 469,030 $8,831,835 0.68%
Fidelity Small Cap Value Fund 465,000 $8,755,950 0.16%
Fidelity Enhanced Small Cap Core ETF 434,295 $8,125,659 0.14%
Fidelity Series Small Cap Discovery Fund 424,300 $7,989,569 0.41%
Franklin Biotechnology Discovery Fund 404,940 $7,625,020 0.66%
JNL Multi-Manager Small Cap Value Fund 405,228 $7,581,816 0.38%
Fidelity SAI Small-Mid Cap Momentum Index Fund 402,432 $7,577,795 0.18%
Small Cap Value Fund 396,435 $7,417,299 1.08%
Schwab Small-Cap Index Fund 392,508 $7,390,926 0.10%
EQ/AB Small Cap Growth Portfolio 393,352 $7,359,616 0.33%
VANGUARD STRATEGIC EQUITY FUND 389,501 $7,287,564 0.06%
VIP Health Care Portfolio 376,000 $7,034,960 0.61%
T. Rowe Price Institutional Small-Cap Stock Fund 374,354 $7,004,163 0.14%
Dimensional U.S. Core Equity 2 ETF 318,808 $6,003,155 0.01%
SmallCap Growth Fund I 318,751 $6,002,081 0.24%
iShares Russell 2000 Value ETF 316,655 $5,924,615 0.04%
Master Small Cap Index Series 295,806 $5,534,530 0.09%
Showing 1–50 of 293 positions
Key facts CIK 1812364 CUSIP 75943R102 13F (30d) 24 filings 24 filers Visit website Investor relations